Literature DB >> 7903102

Modulation of murine macrophage function by IL-13.

T M Doherty1, R Kastelein, S Menon, S Andrade, R L Coffman.   

Abstract

Activated macrophages are important effector cells for immune response to many parasites and immune responses are strongly modulated in part by the effect of Th cell-derived cytokines on macrophages. Th1-derived cytokines such as IFN-gamma are strong stimulators of macrophage activation, while cytokines produced by Th2 cells, including IL-4 and IL-10, have been shown under some conditions to inhibit macrophage activities associated with inflammatory responses. IL-13, a recently described cytokine produced by Th2 cells, is also capable of down-modulating macrophage activity in a manner similar to that previously described for IL-4. Treatment of activated macrophages with IL-13 reduces the production of inflammatory monokines in response to IFN-gamma or LPS, both potent stimulators of these factors. In addition, IL-13 decreases the production of nitric oxide by activated macrophages. Nitric oxide has been implicated in both macrophage cytotoxicity and macrophage-associated immunosuppression. The suppression of nitric oxide by IL-13 leads to a decrease in parasiticidal activity by activated macrophages. However, our data indicate that IL-13 has pleiotropic effects, while the inflammatory potential of activated macrophages is significantly reduced, the potential of other macrophage subsets is unimpaired. These data indicate that IL-13 could be a potent modulator of immune responses in vivo, with effects that may embrace both macrophage suppressive and macrophage potentiating functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903102

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

2.  Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13.

Authors:  N E Saadé; I W Nasr; C A Massaad; B Safieh-Garabedian; S J Jabbur; S A Kanaan
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages.

Authors:  Katarzyna Maresz; Eugene D Ponomarev; Natasha Barteneva; Yanping Tan; Monica K Mann; Bonnie N Dittel
Journal:  J Reprod Immunol       Date:  2008-03-07       Impact factor: 4.054

4.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

Review 5.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

6.  Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.

Authors:  Andrew M Donson; Diane K Birks; Stephanie A Schittone; Bette K Kleinschmidt-DeMasters; Derrick Y Sun; Molly F Hemenway; Michael H Handler; Allen E Waziri; Michael Wang; Nicholas K Foreman
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

7.  Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation.

Authors:  M Goebeler; B Schnarr; A Toksoy; M Kunz; E B Bröcker; A Duschl; R Gillitzer
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 8.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

9.  The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.

Authors:  Faruk Sheikh; Harold Dickensheets; Joao Pedras-Vasconcelos; Thirumalai Ramalingam; Laura Helming; Siamon Gordon; Raymond P Donnelly
Journal:  J Innate Immun       Date:  2015-03-07       Impact factor: 7.349

10.  Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice.

Authors:  Violeta Chitu; Polly J Ferguson; Rosalie de Bruijn; Annette J Schlueter; Luis A Ochoa; Thomas J Waldschmidt; Yee-Guide Yeung; E Richard Stanley
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.